![]() |
Volumn 8, Issue 3, 2002, Pages 128-135
|
African-American Heart Failure Trial (A-HeFT): Rationale, design, and methodology
a
|
Author keywords
BiDil; Hydralazine isosorbide dinitrate vasodilators
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
PLACEBO;
VASODILATOR AGENT;
ISOSORBIDE HYDRALAZINE COMBINATION;
ISOSORBIDE-HYDRALAZINE COMBINATION;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE SIZE;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
METHODOLOGY;
MORTALITY;
NEGRO;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
ADOLESCENT;
AGED;
CONGESTIVE HEART FAILURE;
DRUG COMBINATION;
HEART LEFT VENTRICLE FUNCTION;
INFORMED CONSENT;
MIDDLE AGED;
PATIENT SELECTION;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AFRICAN CONTINENTAL ANCESTRY GROUP;
AGED;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDRALAZINE;
INFORMED CONSENT;
ISOSORBIDE DINITRATE;
MALE;
MIDDLE AGED;
PATIENT SELECTION;
RESEARCH DESIGN;
TREATMENT OUTCOME;
VASODILATOR AGENTS;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 0036023202
PISSN: 10719164
EISSN: None
Source Type: Journal
DOI: 10.1054/jcaf.2002.124730 Document Type: Article |
Times cited : (86)
|
References (29)
|